ONO 5788
Alternative Names: ONO-5788Latest Information Update: 28 Mar 2022
At a glance
- Originator Ono Pharmaceutical
- Class Small molecules
- Mechanism of Action Growth hormone-releasing hormone inhibitors; Somatostatin receptor 2 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Acromegaly
Most Recent Events
- 28 Mar 2022 No recent reports of development identified for phase-I development in Acromegaly(In volunteers) in Netherlands (IV, Infusion)
- 28 Mar 2022 No recent reports of development identified for phase-I development in Acromegaly(In volunteers) in Netherlands (PO, Capsule)
- 28 Jul 2021 No recent reports of development identified for phase-I development in Acromegaly(In volunteers) in USA (PO, Capsule)